Head and neck cancer trials in China

In China 216 Also abroad 944

216 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC
Where
Shenzhen
Age
18 years to 75 years
People
42
Run by
Beijing Biotech
See details and how to joinNCT07617805
Phase 2Enrolling by invitation
BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression
Where
Foshan, Guangzhou, Shantou, Shenzhen, Zhanjiang
Age
18 years to 75 years
People
42
Run by
Sun Yat-sen University
See details and how to joinNCT07618624
Phase 2/3Taking people
Trop2-targeted immunoPET Imaging of Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
400
Run by
RenJi Hospital
See details and how to joinNCT06851663
Phase 3Taking people
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Where
Baoding, Beijing, Changsha, Changzhou, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Hefei, Hengyang, Jinan, Kunming, Lanzhou, Linyi, Nanchang, Nanning, Nanyang, Shanghai, Taiyuan, Wuhan, Xiamen, Xuzhou, Zhengzhou, Zhuhai
Age
18 years and over
People
864 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06256588 · EU 2023-508613-17-00
Phase 1/2Not yet taking people in China
Treatment of Recurrent/Metastatic Head and Neck Cancer
Where
Beijing, Changsha, Chengdu, Guangzhou, Nanning, Shenyang, Taiyuan, Tianjin, Wuhan
Age
18 years to 75 years
People
128
Run by
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
See details and how to joinNCT07601204
Phase 2Not yet taking people in China
Becotatug Vedotin Combined With Pucotenlimab as Neoadjuvant Therapy for Resectable Recurrent Head and Neck Squamous Cell Carcinoma After Progression on Immunotherapy: A Prospective Phase II Study
Where
Foshan, Ganzhou, Guangzhou, Qingyuan, Shantou, Shenzhen, Zhanjiang
Age
18 years to 75 years
People
42
Run by
Sun Yat-sen University
See details and how to joinNCT07589049
No phaseTaking people
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Where
Beijing
Age
18 years and over
People
200
Run by
Peking University First Hospital
See details and how to joinNCT07557225
Phase 2Taking people
Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma
Where
Chengdu
Age
18 years and over
People
30
Run by
West China Hospital
See details and how to joinNCT07492914
Phase 1Not yet taking people in China
A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors
Where
Beijing
Age
18 years and over
People
192
Run by
Corregene Biotechnology Co., Ltd
See details and how to joinNCT07583316
Phase 1Taking people
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Where
Guangzhou
Age
2 years to 18 years
People
51
Run by
Sun Yat-sen University
See details and how to joinNCT07584499
Phase 1Taking people
Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC
Where
Beijing
Age
18 years to 75 years
People
10
Run by
Beijing Tongren Hospital
See details and how to joinNCT07040072
No phaseTaking people
A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.
Where
Guangzhou
Age
20 years to 70 years
People
524
Run by
Jinsong Hou
See details and how to joinNCT02743832
Phase 2Not yet taking people in China
Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC
Where
Nanchang
Age
18 years to 75 years
People
25
Run by
Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07041788
Phase 1Taking people
Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy
Where
Chengdu
Age
18 years to 75 years
People
6
Run by
West China Hospital
See details and how to joinNCT07545967
Phase 2Not yet taking people in China
Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC
Where
Guangzhou
Age
18 years to 70 years
People
36
Run by
Chen Chunyan
See details and how to joinNCT07554768
No phaseTaking people
Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors
Where
Shanghai
Age
18 years to 70 years
People
32
Run by
Grit Biotechnology
See details and how to joinNCT06190275
Phase 2Enrolling by invitation
Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.
Where
Hangzhou
Age
18 years to 75 years
People
30
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT07550972
No phaseTaking people
A Study Investigating the Efficacy and Safety of the Combination of Iparomlimab and Tuvonralimab With or Without Chemotherapy in Second-line and Subsequent Treatments for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Where
Haikou
Age
18 years to 75 years
People
32
Run by
The Second Affiliated Hospital of Hainan Medical University
See details and how to joinNCT07546383
Phase 3Taking people
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
Where
Shanghai
Age
18 years and over
People
370
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07445048
No phaseTaking people
ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer
Where
Chengdu
Age
18 years to 80 years
People
40
Run by
West China Hospital
See details and how to joinNCT07081074
No phaseTaking people
ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer
Where
Chengdu
Age
18 years to 80 years
People
5
Run by
West China Hospital
See details and how to joinNCT07086638
Phase 3Taking people
Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Where
Zhuhai
Age
18 years to 75 years
People
430
Run by
Ming-Yuan Chen
See details and how to joinNCT07524452
Phase 1/2Taking people
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Where
Changchun, Changsha, Chengdu, Nanjing, Shanghai, Shenyang, Wuxi, Zhengzhou
Age
18 years and over
People
1,000 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT05785741
No phaseTaking people
Topical Diclofenac for Prevention of Radiation-induced Dermatitis
Where
Haikou
Age
18 years to 75 years
People
156
Run by
The Second Affiliated Hospital of Hainan Medical University
See details and how to joinNCT06905561
No phaseTaking people
FL-261 Imaging for Cancer Diagnosis and Staging
Where
Wuhan
Age
18 years and over
People
12
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07510321